| 16th Feb 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 11th Feb 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 11th Feb 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 11th Feb 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 11th Feb 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 10th Feb 2026 7:00 am |
RNS |
China CDE accepts Arexvy adults 60+ application |
| 9th Feb 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 6th Feb 2026 10:30 am |
RNS |
Director/PDMR Shareholding |
| 6th Feb 2026 7:00 am |
RNS |
Nucala COPD approved by the European Commission |
| 5th Feb 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 4th Feb 2026 7:00 am |
RNS |
Final Results |
| 2nd Feb 2026 3:00 pm |
RNS |
Total Voting Rights |
| 26th Jan 2026 7:00 am |
RNS |
European Commission approves Arexvy for adults 18+ |
| 20th Jan 2026 7:05 am |
RNS |
GSK to acquire RAPT Therapeutics |
| 20th Jan 2026 7:00 am |
RNS |
Agreement on changes to ViiV minority shareholding |
| 16th Jan 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 15th Jan 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jan 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 7th Jan 2026 7:05 am |
RNS |
EC approval of Shingrix PFS |
| 7th Jan 2026 7:00 am |
RNS |
Positive phase 3 data for GSK's bepirovirsen |
| 6th Jan 2026 7:00 am |
RNS |
Exdensur approved in Japan |
| 5th Jan 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 5th Jan 2026 3:00 pm |
RNS |
Total Voting Rights |
| 5th Jan 2026 7:00 am |
RNS |
Nucala for adults with COPD approved in China |
| 22nd Dec 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 22nd Dec 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 22nd Dec 2025 7:00 am |
RNS |
GSK to lower drug prices and expand access in US |
| 22nd Dec 2025 7:00 am |
RNS |
GSK to lower drug prices and expand access in US |
| 22nd Dec 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 22nd Dec 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 19th Dec 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 19th Dec 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 18th Dec 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 17th Dec 2025 7:00 am |
RNS |
Exdensur (depemokimab ulla) approved by US FDA |
| 17th Dec 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Dec 2025 7:00 am |
RNS |
Exdensur (depemokimab) UK MHRA approval |
| 16th Dec 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 15th Dec 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 12th Dec 2025 1:50 pm |
RNS |
Nucala receives positive CHMP opinion for COPD |
| 12th Dec 2025 1:41 pm |
RNS |
Depemokimab receives positive CHMP opinion |
